Publication details

Zpráva o průběhu klinického hodnocení Annual Report KDO_DC1311 za období 10. září 2022 ‒ 9. září 2023

Title in English Progress Report of the clinical evaluation Annual Report KDO_DC1311 for the period September 10, 2022 - September 9, 2023
Authors

DEMLOVÁ Regina KUBÁTOVÁ Jana

Year of publication 2023
MU Faculty or unit

Faculty of Medicine

Web KDO_DC1311
Description The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info